Search

Author/Creator Ozgun, Alpaslan

3. Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case series. Issue 6 (23rd September 2022)

Authors:
Smith, Jessica Louise; Menzies, Alexander M.; Cohen, Justine V.; Mut-Lloret, Margarida; Ozgun, Alpaslan; Spain, Lavinia; Park, John; Quach, Henry T.; Pallan, Lalit; McQuade, Jennifer; Feng, Sophie; Sandhu, Shahneen; Atkinson, Victoria; Tsai, Katy; Long, Georgina V.; Larkin, James; Eroglu, Zeynep;...
Journal:
Melanoma research
Issue:
Volume 32:Issue 6(2022)
Page Start:
451
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy. Issue 1 (21st February 2017)

Authors:
Shiuan, Eileen; Beckermann, Kathryn E.; Ozgun, Alpaslan; Kelly, Ciara; McKean, Meredith; McQuade, Jennifer; Thompson, Mary Ann; Puzanov, Igor; Greer, John P.; Rapisuwon, Suthee; Postow, Michael; Davies, Michael A.; Eroglu, Zeynep; Johnson, Douglas
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 5:Issue 1(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy. Issue 1 (December 2017)

Authors:
Shiuan, Eileen; Beckermann, Kathryn; Ozgun, Alpaslan; Kelly, Ciara; McKean, Meredith; McQuade, Jennifer; Thompson, Mary; Puzanov, Igor; Greer, John; Rapisuwon, Suthee; Postow, Michael; Davies, Michael; Eroglu, Zeynep; Johnson, Douglas
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 5:Issue 1(2017)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗